Physician profile
Joseph A Brown
NPI 1679505705
$664.30
in general payments reported to CMS, 2019-2025
16 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $14.14 · 2021: $138 · 2022: $15.04 · 2023: $48.41 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $107.88 | 2019 | |
| Smith+Nephew, INC. | $104.22 | 2021-2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $90.47 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| W. L. Gore & Associates, INC. | $67.36 | 2019 | |
| Urgo Medical North America, LLC | $57.95 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Mallinckrodt Hospital Products INC. | $43.53 | 2021-2023 | Terlivaz |
| Ethicon US, LLC | $27.46 | 2025 | Vistaseal, Surgicel Nu-Knit |
| Reapplix INC. | $25.46 | 2025 | 3c Patch Kit - Box |
| Cashflow Solutions, LLC | $24.44 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Myriad Genetic Laboratories, INC. | $23.01 | 2021 | |
| Melinta Therapeutics, LLC | $18.77 | 2019 | |
| Kci USA, INC. | $18.09 | 2023 | Activ.A.C., Promogran Prisma |
| Novo Nordisk INC | $16.05 | 2023 | |
| Cook Medical LLC | $15.03 | 2021 | |
| Tactile Systems Technology INC | $14.14 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $10.44 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.